# Can Cerebrolysin reduce inflammation and apoptosis in spinal cord injury models?

Canonical source: https://retacompare.com/research/can-cerebrolysin-reduce-inflammation-and-apoptosis-in-spinal-cord-injury-models

Peptide Longevity Q&A · 2026-03-01


    Research indicates that Cerebrolysin-loaded exosomes significantly reduce inflammation and apoptosis in a mouse model of spinal cord injury, enhancing neuronal survival and promoting tissue repair, which could have implications for therapies targeting age-related neurodegenerative conditions.

 What the research shows

This study investigated the effects of Cerebrolysin (CBL), platelet-rich plasma (PRP)-derived exosomes (Exo), and Cerebrolysin-loaded exosomes (CLE) in a mouse model of spinal cord injury (SCI). The research involved sixty healthy adult female BALB/c mice, aged 8-10 weeks, subjected to SCI through compression. The treatments aimed to evaluate their impact on inflammation, apoptosis, tissue organization, and motor function recovery. Key measurements included the expression levels of apoptotic markers Bax and Bcl2, inflammatory markers TNF-α and IL-10, histological assessments of tissue organization, and motor function recovery as measured by the Basso-Beattie-Bresnahan (BBB) locomotor scale.

 Why it matters for longevity

Reducing inflammation and apoptosis is critical for promoting longevity and healthspan, particularly in aging populations. The findings from this study suggest that Cerebrolysin-loaded exosomes could play a role in mitigating the effects of neuroinflammation and cellular apoptosis, both of which are associated with age-related neurodegenerative diseases. By enhancing neuronal survival and promoting tissue repair, such treatments may offer new avenues for improving cognitive and motor functions in older adults, thereby potentially extending healthspan and quality of life.

 Key findings at a glance

Cerebrolysin-loaded exosomes significantly modulated Bax and Bcl2 expression, reducing apoptosis.

Levels of TNF-α decreased, indicating reduced inflammation.

IL-10 levels increased, demonstrating anti-inflammatory effects.

Histological assessments showed improved tissue organization.

Motor function recovery was significantly enhanced as measured by BBB scores.

Cerebrolysin-loaded exosomes exhibited neuroprotective and anti-inflammatory effects.

 How Cerebrolysin works (background)

Cerebrolysin is a peptide mixture derived from porcine brain tissue, known for its neuroprotective properties. It is believed to exert its effects through various mechanisms, including modulation of neuronal survival pathways, reduction of inflammation, and promotion of neurotrophic factors. In this study, the combination of Cerebrolysin with exosomes derived from platelet-rich plasma may enhance its delivery and efficacy, targeting the cellular processes involved in apoptosis and inflammation. This mechanism is particularly relevant in the context of spinal cord injury and potentially in other neurodegenerative conditions associated with aging.

 Safety, caveats, and what we don't yet know

While the study presents promising results regarding Cerebrolysin-loaded exosomes, it is important to note that the research was conducted in a controlled laboratory setting using a specific mouse model. The findings may not directly translate to human populations or other types of injuries. Further research is needed to explore the long-term safety and efficacy of these treatments in larger, more diverse populations, as well as their potential applications in age-related neurodegenerative diseases.

 Bottom line

Cerebrolysin-loaded exosomes have demonstrated the ability to reduce inflammation and apoptosis in a mouse model of spinal cord injury, suggesting their potential as a therapeutic candidate for enhancing neuronal survival and promoting tissue repair, with implications for age-related conditions.

 Related questions

 Does Cerebrolysin improve cognitive function in aging populations?

Research indicates that Cerebrolysin may enhance cognitive function by promoting neuronal survival and reducing inflammation, potentially benefiting aging populations.

 How does inflammation affect aging and longevity?

Chronic inflammation is linked to various age-related diseases, and reducing inflammation may improve healthspan and longevity by mitigating these effects.

 What are the implications of exosome therapy for neurodegenerative diseases?

Exosome therapy, particularly with agents like Cerebrolysin, may offer a novel approach to treating neurodegenerative diseases by enhancing cellular communication and promoting repair mechanisms.

 Source: PubMed · J Spinal Cord Med · published 2026-03-01.

## Sources

- PubMed · J Spinal Cord Med: https://pubmed.ncbi.nlm.nih.gov/40470992/